Pat Gleason, PharmD, FCCP, FAMCP, BCPS
Assistant Vice President, Health Outcomes, Prime Therapeutics
As assistant vice president, health outcomes, at Prime Therapeutics (Prime), Dr. Pat Gleason leads Prime’s clinical health outcomes assessment team in developing and improving pharmacy benefit management programs. Through integrated medical and pharmacy claims data analysis, he assesses clinical program opportunities and post-implementation outcomes. In addition, he negotiates and fulfills reporting for value-based contracts with pharmaceutical manufacturers.
Dr. Gleason has more than 40 peer-reviewed publications in medical and health policy journals, including the Journal of Managed Care & Specialty Pharmacy (JMCP), Medical Care, Health Affairs and JAMA: The Journal of the American Medical Association.
Dr. Gleason is on the board of directors for the Academy of Managed Care Pharmacy (AMCP), is a past chair of the JMCP Editorial Advisory Board and currently serves as an adjunct professor at the University of Minnesota, College of Pharmacy. He is a board-certified pharmacotherapy specialist (BCPS), an elected Fellow of the American College of Clinical Pharmacy (FCCP) and an elected Fellow of the Academy of Managed Care Pharmacy (FAMCP).
Dr. Gleason earned his Bachelor of Science and Pharmacy Doctorate degrees at the University of Minnesota. He completed an ambulatory care pharmacy practice residency at the University of Pittsburgh Medical Center and a fellowship in outcomes research through the University of Pittsburgh, School of Pharmacy.